Clostridium Tetani, Toksoid, Difteritoksoid, Filamentøst Hemagglutinin, Pertaktin, Pertussistoksoid, Poliovirus Type 1, Inaktivert, Poliovirus Type 2, Inaktivert, Poliovirus Type 3, Inaktivert shortage — BE supply status & alternatives | Mederti
Clostridium Tetani, Toksoid, Difteritoksoid, Filamentøst Hemagglutinin, Pertaktin, Pertussistoksoid, Poliovirus Type 1, Inaktivert, Poliovirus Type 2, Inaktivert, Poliovirus Type 3, Inaktivert
—
In supply · Australia
Boostrix Polio injeksjonsvæske, suspensjon i ferdigfylt sprøyte, 10x0
In supply · 🇦🇺 Australia · short in🇧🇪 BE
In supply in Australia
Reading today’s signals…
Ask Mederti to source this on your behalf
✓ Can I substitute?
In supply
no shortage substitution needed
⇄ Best alternative
None listed
refer to prescriber
◷ Expected back
No estimate
No estimate provided
Product attributes reference data we hold
Active ingredient (INN)
Clostridium Tetani, Toksoid, Difteritoksoid, Filamentøst Hemagglutinin, Pertaktin, Pertussistoksoid, Poliovirus Type 1, Inaktivert, Poliovirus Type 2, Inaktivert, Poliovirus Type 3, Inaktivert
Brand names
Boostrix Polio injeksjonsvæske, suspensjon i ferdigfylt sprøyte, 10x0
Therapeutic category
Auto-created by NoMA (Norwegian Medicines Agency / DMP) scraper
Controlled substance
No
Patient information leaflet (PIL)
Not on file
Summary of product characteristics (SPC)
Not on file
Trade price 🇦🇺 Australia · awaiting price ingest
🇦🇺 AU
Ex-manufacturer
—
Dispensed (DPMQ)
—
Pack
—
$
Not yet captured for Australia
Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.
Substitution pathways 🇦🇺 Australia · TGA
—
No substitution instrument in force
Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.
How long have past shortages lasted? from 9 resolved events
◷
1–38 months
Historical pattern from resolved shortage records — not a prediction of this event.
Generated 3 July 2026 · Australia market · 2 regulatory sources
For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.